Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: IEEE Trans Neural Syst Rehabil Eng. 2007 Jun;15(2):173–181. doi: 10.1109/TNSRE.2007.896997

TABLE I.

Patient Characteristics

Age (yrs) Gender Post-surgical UPDRS a Off Treatment DBS Parameters Anti-Parkinsonian Medications

Item 22 Stim Level (V) Electrode Contacts
66 F 3 2.8 1C+ Carbidopa/Levodopa CR 50/200 2 tabs
Amantadine 100mg 1 tab
64 F 3 3.0 1C+ Carbidopa/Levodopa
25/250 1 tab
Trihexyphenidyl 2mg 1 tab
Carbidopa 25 mg 1 tab
66 F 2 3.6 1C+ Carbidopa/Levodopa 25/100 1.5 tabs
Carbidopa/Levodopa CR 50/200 1 tab
Amantadine 100 mg 1 tab
Ropinirole 2 mg 1 tab
67 F 1 2.3 0C+ Carbidopa/Levodopa 25/100 1 tab
Carbidopa/Levodopa CR 25/100 1 tab
Amantadine 100mg 1 tab
Pramipexole 1 mg 1 tab
72 F 1 4.0 0C+ Carbidopa/Levodopa 25/100 1.5 tabs
64 F 3 3.6 0123+ Carbidopa/Levodopa 25/100 1 tab
Amantadine 100 mg 1 tab
Ropinirole 5 mg 1 tab
50 M 3 2.5 1C−+ Carbidopa/Levodopa 25/100 1 tab
Carbidopa/Levodopa CR 50/200 1 tab
Pergolide 1 mg 1 tab
Amantadine 100 mg 1 tab
64 M 1 1.7 1C+ Carbidopa/Levodopa 25/100 1 tab
Amantadine 100 mg 1 tab
Pramipexole 0.5 mg 1 tab
Entacapone 200 mg 1 tab
57 M 2 3.0 2C+ Carbidopa/Levodopa 10/100 2 tabs
Entacapone 200 mg 1 tab
Pramipexole 1 mg 0.5 tabs
70 M 1 3.5 1C+ Carbidopa/Levodopa t 25/100 3 tabs
a

UPDRS = Unified Parkinson’s Disease Rating Scale